Latest Articles

Publication Date
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic - biospace.com

EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic biospace.com

Published: Sept. 17, 2025, 7:44 a.m.
Noninvasive Detection and Thermal Ablation Therapy of Endometriosis Using Silica-Coated Gold Nanorods.

Endometriosis (EM) is a gynecological disease where endometrial tissue grows outside the uterus. Current diagnostic methods are mainly through surgical visualization with histological verification; there's a need for noninvasive approaches. …

Published: Sept. 17, 2025, midnight
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic - PR Newswire

EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic PR Newswire

Published: Sept. 16, 2025, 1 p.m.
M2 Macrophages are Major Mediators of Germline Risk of Endometriosis and Explain Pleiotropy With Comorbid Traits.

Endometriosis is a common gynecologic condition that causes chronic, life-altering symptoms including pain and infertility. There is an urgent need for new non-hormonal targeted therapeutics to treat endometriosis, but until …

Published: Sept. 12, 2025, midnight
United States Endometriosis Therapeutics Market Set for Robust - openPR.com

United States Endometriosis Therapeutics Market Set for Robust openPR.com

Published: Sept. 11, 2025, 9:57 a.m.
Real time breakdown of Brainstorm Cell Therapeutics Inc. stock performance - 2025 Analyst Calls & Momentum Based Trading Signals - Newser

Real time breakdown of Brainstorm Cell Therapeutics Inc. stock performance - 2025 Analyst Calls & Momentum Based Trading Signals Newser

Published: Aug. 22, 2025, 6:09 p.m.
Endometriosis-Associated Infertility: Multi-Omics Insights into Pathogenesis and Precision Therapeutics - Frontiers

Endometriosis-Associated Infertility: Multi-Omics Insights into Pathogenesis and Precision Therapeutics Frontiers

Published: Aug. 15, 2025, 1:08 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times

Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights The Manila Times

Published: Aug. 13, 2025, 8:31 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewswire

Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights GlobeNewswire

Published: Aug. 13, 2025, 8:17 p.m.
Karyopharm Therapeutics Inc. SEC 10-Q Report - TradingView

Karyopharm Therapeutics Inc. SEC 10-Q Report TradingView

Published: Aug. 11, 2025, 11:43 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!